Taraseviciene-Stewart L - Search Results

1

The pathobiology of pulmonary hypertension. Endothelium.

Tuder RM, Cool CD, Yeager M, Taraseviciene-Stewart L, Bull TM, Voelkel NF. Tuder RM, et al. Clin Chest Med. 2001 Sep;22(3):405-18. doi: 10.1016/s0272-5231(05)70280-x. Clin Chest Med. 2001. PMID: 11590837 Review.

2

Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension.

Achcar RO, Demura Y, Rai PR, Taraseviciene-Stewart L, Kasper M, Voelkel NF, Cool CD. Achcar RO, et al. Chest. 2006 Mar;129(3):696-705. doi: 10.1378/chest.129.3.696. Chest. 2006. PMID: 16537870

3

Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.

Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Mc Mahon G, Waltenberger J, Voelkel NF, Tuder RM. Taraseviciene-Stewart L, et al. FASEB J. 2001 Feb;15(2):427-38. doi: 10.1096/fj.00-0343com. FASEB J. 2001. PMID: 11156958

4

Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis.

Tuder RM, Chacon M, Alger L, Wang J, Taraseviciene-Stewart L, Kasahara Y, Cool CD, Bishop AE, Geraci M, Semenza GL, Yacoub M, Polak JM, Voelkel NF. Tuder RM, et al. J Pathol. 2001 Oct;195(3):367-74. doi: 10.1002/path.953. J Pathol. 2001. PMID: 11673836

5

Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade.

Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasahara Y, Salvemini D, Voelkel NF, Flores SC. Tuder RM, et al. Am J Respir Cell Mol Biol. 2003 Jul;29(1):88-97. doi: 10.1165/rcmb.2002-0228OC. Epub 2003 Jan 31. Am J Respir Cell Mol Biol. 2003. PMID: 12600822

6

The expression of prostacyclin synthase is decreased in the small pulmonary arteries from patients with emphysema.

Lee JD, Taraseviciene-Stewart L, Keith R, Geraci MW, Voelkel NF. Lee JD, et al. Chest. 2005 Dec;128(6 Suppl):575S. doi: 10.1378/chest.128.6_suppl.575S. Chest. 2005. PMID: 16373836 No abstract available.

7

Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease?

Taraseviciene-Stewart L, Douglas IS, Nana-Sinkam PS, Lee JD, Tuder RM, Nicolls MR, Voelkel NF. Taraseviciene-Stewart L, et al. Proc Am Thorac Soc. 2006 Nov;3(8):687-90. doi: 10.1513/pats.200605-105SF. Proc Am Thorac Soc. 2006. PMID: 17065374 Review.

8

Inhibition of VEGF receptors causes lung cell apoptosis and emphysema.

Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF. Kasahara Y, et al. J Clin Invest. 2000 Dec;106(11):1311-9. doi: 10.1172/JCI10259. J Clin Invest. 2000. PMID: 11104784 Free PMC article.

9

Autoimmunity and pulmonary hypertension: a perspective.

Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB, Voelkel NF. Nicolls MR, et al. Eur Respir J. 2005 Dec;26(6):1110-8. doi: 10.1183/09031936.05.00045705. Eur Respir J. 2005. PMID: 16319344 Free article. Review.

10

The protective role of T-lymphocytes in pulmonary vascular remodeling.

Taraseviciene-Stewart L, Scerbavicius DK, Burns N, Cool CD, Nicolls MR, Voelkel NF. Taraseviciene-Stewart L, et al. Chest. 2005 Dec;128(6 Suppl):571S-572S. doi: 10.1378/chest.128.6_suppl.571S-a. Chest. 2005. PMID: 16373829 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters